NeurologyLive Friday 5 — June 5, 2020

June 5, 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 5, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Differential Diagnosis of Multiple Sclerosis

The panel of Fred Lublin, MD; Wallace Brownlee, MBChB, PhD, FRACP; Patricia K. Coyle, MD; and Sven Meuth, MD, PhD, reviews multiple sclerosis guidelines for diagnosis and treatment and reviews the differential diagnosis of MS.

WATCH NOW

2: The Advantages of Independent Contact-Current Controlled DBS Devices

Jerrold L. Vitek, MD, PhD, professor and head of the department of neurology at the University of Minnesota, spoke to the recent findings of a study of Boston Scientific's multiple independent contact current-controlled device for deep brain stimulation.

READ MORE

3: CMSC 2020 Day 3: Mark Freedman, MSc, MD, on Stem Cell Research

The director of the Multiple Sclerosis Research Unit at Ottawa Hospital-General Campus, presents the John F. Kurtzke Lecture, titled "Stem Cell Research Update" as part of the 2020 CMSC Virtual Annual Meeting.

WATCH NOW

4: Novel BTK Inhibitor Evobrutinib Displays Long-Term Success in MS

Robert Henderson, PhD, vice president of Global Program Leadership in Neurology and Immunology at EMD Serono, discussed the recent long-term phase 2 data on evobrutinib presented at CMSC 2020. .

READ MORE

5: Shadi Yaghi, MD: Future Research on Stroke and COVID-19

The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone shares his reaction to data that has been published and what needs to be researched going forward.

WATCH NOW